Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

Total article views   Abstract views HTML views PDF downloads Totals
3,165 Dovepress* 2,698 290+ 794 2,988
PubMed Central* 0 177 50 177
Totals 2,698 467 844 3,165
*Since 30 June 2020
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar